Evidence map›Paper›PMID 37528286›Full record

Observational studyJournal of robotic surgery2023

Urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in relation to surgeon experience.

Jorge Fonseca, Gonçalo Froes, Maria Francisca Moraes-Fontes, Jorge Rebola, Rui Lúcio, Miguel Almeida, Ciprian Muresan, Artur Palmas, Ana Gaivão, Celso Matos and 7 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of robotic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Jorge Fonseca *Unidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal. jorge.fonseca@fundacaochampalimaud.pt.
Gonçalo Froes *Faculté de Médecine et Médecine Dentaire, Université Catholique de Louvain, Brussels, Belgium.
Maria Francisca Moraes-FontesUnidade de Imuno-Oncologia, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Jorge RebolaUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Rui LúcioUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Miguel AlmeidaUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Ciprian MuresanUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Artur PalmasUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Ana GaivãoServiço de Imagiologia, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Celso MatosServiço de Imagiologia, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Tiago SantosUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Daniela DiasUnidade de Próstata, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Inês SousaUnidade de Investigação Clínica, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Francisco OliveiraServiço de Medicina Nuclear, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Ricardo RibeiroInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
Antonio Lopez-BeltranUnidade de Anatomia Patológica, Centro Clínico Champalimaud, Champalimaud Foundation, Lisbon, Portugal.
Avelino FragaInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
Champalimaud Foundation · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary incontinence is one of the main concerns for patients after radical prostatectomy. Differences in surgical experience among surgeons could partly explain the wide range of frequencies observed. Our aim was to evaluate the association between the surgeons` experience and center caseload with relation to urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy (RS-RARP). Prospective observational single-center study. Five surgeons consecutively operated 405 patients between July 2017 and February 2022. Continence recovery was evaluated with pad count and by employing the short form of the International Consultation on Incontinence Questionnaire (ICIQ-SF), pre- and postoperatively at 1 year. Non-parametric tests were used. Median age was 63 years, 30% of patients presented with local advanced disease; the positive surgical margin rate (over 3 mm length) was 16%. Complication rate was 1% (Clavien-Dindo > II). One year after surgery, continence was assessed in 282 patients, of whom 87% were pad free and 51% never leaked (ICIQ-SF = 0). With respect to the mean annual number of procedures per surgeon, divided in < 20, 20-39 and ≥ 40, pad-free rates were achieved in 93%, 85%, and 84% and absence of urine leak rates in 47%, 62% and 48% of patients, respectively. Postoperative median ICIQ-SF was five. We acknowledge the limitation of a 12-month follow-up and the fact that we are a medium-volume center. There is no statistically significant association between continence recovery, surgeon's experience and center caseload. Continence recovery at 1 year after surgery is adequate and robust to surgeon's experience.

Indexed as

RoboticsRobotic Surgical ProceduresSurgeonsUrinary IncontinenceHumansMaleMiddle AgedProstateProstatectomyTreatment OutcomeCaseloadInternational Consultation on Incontinence Questionnaire Short FormLearning curveProstate cancerRetzius-sparing robot-assisted radical prostatectomyUrinary continence recovery

Identifiers

PMID37528286
PMCPMC10492722
OpenAlexW4385452344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.